This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mannkind Corporation. Active years: 2010-2021.
Location History:
- Valencia, CA (US) (2010 - 2016)
- Camarillo, CA (US) (2018 - 2021)
Company Filing History:
Years Active: 2010-2021
Title: Mark Hokenson: Innovator in Drug Formulation
Introduction
Mark Hokenson is a notable inventor based in Valencia, CA (US). He has made significant contributions to the field of drug formulation, holding a total of 7 patents. His work focuses on enhancing the efficacy of active agents in pharmaceutical applications.
Latest Patents
Hokenson's latest patents include a method of drug formulation that promotes the adsorption of active agents to crystalline microparticle surfaces. This innovative approach modifies the structural properties of the active agent to facilitate favorable association with the microparticle. His work in this area aims to improve the delivery and effectiveness of medications.
Career Highlights
Mark Hokenson is currently associated with Mannkind Corporation, where he continues to develop groundbreaking methods in drug formulation. His expertise and dedication to innovation have positioned him as a key figure in the pharmaceutical industry.
Collaborations
Hokenson collaborates with various professionals in his field, including his coworker Keith A Oberg. Their combined efforts contribute to advancing drug formulation techniques and enhancing therapeutic outcomes.
Conclusion
Mark Hokenson's contributions to drug formulation through his innovative patents and collaborations highlight his importance in the pharmaceutical industry. His work continues to pave the way for advancements in medication delivery systems.